| Year |
Citation |
Score |
| 2022 |
Usyk M, Schlecht NF, Pickering S, Williams L, Sollecito CC, Gradissimo A, Porras C, Safaeian M, Pinto L, Herrero R, Strickler HD, Viswanathan S, Nucci-Sack A, Diaz A, Burk RD. molBV reveals immune landscape of bacterial vaginosis and predicts human papillomavirus infection natural history. Nature Communications. 13: 233. PMID 35017496 DOI: 10.1038/s41467-021-27628-3 |
0.424 |
|
| 2021 |
Wright TC, Stoler MH, Ranger-Moore J, Fang Q, Volkir P, Safaeian M, Ridder R. Clinical Validation of p16/Ki-67 Dual-Stained Cytology Triage of HPV-Positive Women - Results from the IMPACT Trial. International Journal of Cancer. PMID 34536311 DOI: 10.1002/ijc.33812 |
0.586 |
|
| 2021 |
Safaeian M, Wright TC, Stoler MH, Ranger-Moore J, Rehm S, Aslam S, Fang Q, Volkir P, Ridder R. The IMPACT trial: human papillomavirus, cervical cytology and histopathological results from the baseline and 1-year follow-up phase. American Journal of Obstetrics and Gynecology. PMID 33852886 DOI: 10.1016/j.ajog.2021.03.047 |
0.587 |
|
| 2020 |
Usyk M, Zolnik CP, Castle PE, Porras C, Herrero R, Gradissimo A, Gonzalez P, Safaeian M, Schiffman M, Burk RD. Cervicovaginal microbiome and natural history of HPV in a longitudinal study. Plos Pathogens. 16: e1008376. PMID 32214382 DOI: 10.1371/Journal.Ppat.1008376 |
0.725 |
|
| 2018 |
Bao X, Hanson AL, Madeleine MM, Wang SS, Schwartz SM, Newell F, Pettersson-Kymmer U, Hemminki K, Tiews S, Steinberg W, Rader JS, Castro F, Safaeian M, Franco EL, Coutlée F, et al. HLA and KIR Associations of Cervical Neoplasia. The Journal of Infectious Diseases. PMID 30099516 DOI: 10.1093/Infdis/Jiy483 |
0.476 |
|
| 2018 |
Safaeian M, Castellsagué X, Hildesheim A, Wacholder S, Schiffman MH, Bozonnat MC, Baril L, Rosillon D. Risk of HPV-16/18 Infections and Associated Cervical Abnormalities in Women Seropositive for Naturally Acquired Antibodies: Pooled Analysis Based on Control Arms of Two Large Clinical Trials. The Journal of Infectious Diseases. PMID 29718393 DOI: 10.1093/Infdis/Jiy112 |
0.744 |
|
| 2018 |
Leo PJ, Madeleine MM, Wang S, Schwartz SM, Newell F, Pettersson-Kymmer U, Hemminki K, Hallmans G, Tiews S, Steinberg W, Rader JS, Castro F, Safaeian M, Franco EL, Coutlée F, et al. Correction: Defining the genetic susceptibility to cervical neoplasia-A genome-wide association study. Plos Genetics. 14: e1007257. PMID 29494589 DOI: 10.1371/Journal.Pgen.1007257 |
0.349 |
|
| 2018 |
Lang Kuhs KA, Lin SW, Hua X, Schiffman M, Burk RD, Rodriguez AC, Herrero R, Abnet CC, Freedman ND, Pinto LA, Hamm D, Robins H, Hildesheim A, Shi J, Safaeian M. T cell receptor repertoire among women who cleared and failed to clear cervical human papillomavirus infection: An exploratory proof-of-principle study. Plos One. 13: e0178167. PMID 29385144 DOI: 10.1371/Journal.Pone.0178167 |
0.735 |
|
| 2018 |
Kreimer AR, Herrero R, Sampson JN, Porras C, Lowy DR, Schiller JT, Schiffman M, Rodriguez AC, Chanock S, Jimenez S, Schussler J, Gail MH, Safaeian M, Kemp TJ, Cortes B, et al. Evidence for single-dose protection by the bivalent HPV vaccine-Review of the Costa Rica HPV vaccine trial and future research studies. Vaccine. PMID 29366703 DOI: 10.1016/J.Vaccine.2017.12.078 |
0.623 |
|
| 2018 |
Safaeian M, Sampson JN, Pan Y, Porras C, Kemp TJ, Herrero R, Quint W, van Doorn LJ, Schussler J, Lowy DR, Schiller J, Schiffman MT, Rodriguez AC, Gail MH, Hildesheim A, et al. Durability of Protection Afforded by Fewer Doses of the HPV16/18 Vaccine: The CVT Trial. Journal of the National Cancer Institute. 110. PMID 28954299 DOI: 10.1093/Jnci/Djx158 |
0.674 |
|
| 2017 |
Leo PJ, Madeleine MM, Wang S, Schwartz SM, Newell F, Kymmer U, Hemminki K, Hallmans G, Tiews S, Steinberg W, Rader JS, Castro F, Safaeian M, Franco EL, Coutlée F, et al. Defining the genetic susceptibility to cervical neoplasia-A genome-wide association study. Plos Genetics. 13: e1006866. PMID 28806749 DOI: 10.1371/Journal.Pgen.1006866 |
0.574 |
|
| 2016 |
Beachler DC, Kreimer AR, Schiffman M, Herrero R, Wacholder S, Rodriguez AC, Lowy DR, Porras C, Schiller JT, Quint W, Jimenez S, Safaeian M, Struijk L, Schussler J, Hildesheim A, et al. Multisite HPV16/18 Vaccine Efficacy Against Cervical, Anal, and Oral HPV Infection. Journal of the National Cancer Institute. 108. PMID 26467666 DOI: 10.1093/Jnci/Djv302 |
0.711 |
|
| 2015 |
Beachler DC, Jenkins G, Safaeian M, Kreimer AR, Wentzensen N. Natural acquired immunity against subsequent genital HPV infection: a systematic review and meta-analysis. The Journal of Infectious Diseases. PMID 26690341 DOI: 10.1093/Infdis/Jiv753 |
0.68 |
|
| 2015 |
Gonzalez P, Hildesheim A, Herrero R, Katki H, Wacholder S, Porras C, Safaeian M, Jimenez S, Darragh TM, Cortes B, Befano B, Schiffman M, Carvajal L, Palefsky J, Schiller J, et al. Rationale and design of a long term follow-up study of women who did and did not receive HPV 16/18 vaccination in Guanacaste, Costa Rica. Vaccine. 33: 2141-51. PMID 25796338 DOI: 10.1016/J.Vaccine.2015.03.015 |
0.709 |
|
| 2015 |
Kemp TJ, Matsui K, Shelton G, Safaeian M, Pinto LA. A comparative study of two different assay kits for the detection of secreted alkaline phosphatase in HPV antibody neutralization assays. Human Vaccines & Immunotherapeutics. 11: 337-46. PMID 25695397 DOI: 10.4161/21645515.2014.990851 |
0.612 |
|
| 2015 |
Kreimer AR, Sherman ME, Sahasrabuddhe VV, Safaeian M. The case for conducting a randomized clinical trial to assess the efficacy of a single dose of prophylactic HPV vaccines among adolescents. Journal of the National Cancer Institute. 107. PMID 25650316 DOI: 10.1093/Jnci/Dju436 |
0.605 |
|
| 2014 |
Robbins HA, Waterboer T, Porras C, Kemp TJ, Pawlita M, Rodriguez AC, Wacholder S, Gonzalez P, Schiller JT, Lowy DR, Esser M, Matys K, Poncelet S, Herrero R, Hildesheim A, ... ... Safaeian M, et al. Immunogenicity assessment of HPV16/18 vaccine using the glutathione S-transferase L1 multiplex serology assay. Human Vaccines & Immunotherapeutics. 10: 2965-74. PMID 25483632 DOI: 10.4161/21645515.2014.972811 |
0.65 |
|
| 2014 |
Safaeian M, Rodriguez AC. Invited commentary: multiple human papillomavirus infections and type replacement-anticipating the future after human papillomavirus vaccination. American Journal of Epidemiology. 180: 1076-81. PMID 25355444 DOI: 10.1093/Aje/Kwu265 |
0.671 |
|
| 2014 |
LaMontagne DS, Mugisha E, Pan Y, Kumakech E, Ssemaganda A, Kemp TJ, Cover J, Pinto LA, Safaeian M. Immunogenicity of bivalent HPV vaccine among partially vaccinated young adolescent girls in Uganda. Vaccine. 32: 6303-11. PMID 25218297 DOI: 10.1016/J.Vaccine.2014.08.071 |
0.649 |
|
| 2014 |
Lang Kuhs KA, Porras C, Schiller JT, Rodriguez AC, Schiffman M, Gonzalez P, Wacholder S, Ghosh A, Li Y, Lowy DR, Kreimer AR, Poncelet S, Schussler J, Quint W, van Doorn LJ, ... ... Safaeian M, et al. Effect of different human papillomavirus serological and DNA criteria on vaccine efficacy estimates. American Journal of Epidemiology. 180: 599-607. PMID 25139208 DOI: 10.1093/Aje/Kwu168 |
0.75 |
|
| 2014 |
Safaeian M, Johnson LG, Yu K, Wang SS, Gravitt PE, Hansen JA, Carrington M, Schwartz SM, Gao X, Hildesheim A, Madeleine MM. Human Leukocyte Antigen Class I and II Alleles and Cervical Adenocarcinoma. Frontiers in Oncology. 4: 119. PMID 24995157 DOI: 10.3389/Fonc.2014.00119 |
0.569 |
|
| 2014 |
Lang Kuhs KA, Gonzalez P, Rodriguez AC, van Doorn LJ, Schiffman M, Struijk L, Chen S, Quint W, Lowy DR, Porras C, DelVecchio C, Jimenez S, Safaeian M, Schiller JT, Wacholder S, et al. Reduced prevalence of vulvar HPV16/18 infection among women who received the HPV16/18 bivalent vaccine: a nested analysis within the Costa Rica Vaccine Trial. The Journal of Infectious Diseases. 210: 1890-9. PMID 24958910 DOI: 10.1093/Infdis/Jiu357 |
0.725 |
|
| 2014 |
Kreimer AR, Safaeian M, Hildesheim A. Number of human papillomavirus vaccine doses and condyloma. Jama. 311: 2439. PMID 24938569 DOI: 10.1001/Jama.2014.5009 |
0.443 |
|
| 2014 |
Castellsagué X, Naud P, Chow SN, Wheeler CM, Germar MJ, Lehtinen M, Paavonen J, Jaisamrarn U, Garland SM, Salmerón J, Apter D, Kitchener H, Teixeira JC, Skinner SR, Limson G, ... ... Safaeian M, et al. Risk of newly detected infections and cervical abnormalities in women seropositive for naturally acquired human papillomavirus type 16/18 antibodies: analysis of the control arm of PATRICIA. The Journal of Infectious Diseases. 210: 517-34. PMID 24610876 DOI: 10.1093/Infdis/Jiu139 |
0.695 |
|
| 2014 |
Robbins HA, Li Y, Porras C, Pawlita M, Ghosh A, Rodriguez AC, Schiffman M, Wacholder S, Kemp TJ, Gonzalez P, Schiller J, Lowy D, Esser M, Matys K, Quint W, ... ... Safaeian M, et al. Glutathione S-transferase L1 multiplex serology as a measure of cumulative infection with human papillomavirus. Bmc Infectious Diseases. 14: 120. PMID 24588945 DOI: 10.1186/1471-2334-14-120 |
0.708 |
|
| 2014 |
Robbins HA, Kemp TJ, Porras C, Rodriguez AC, Schiffman M, Wacholder S, Gonzalez P, Schiller J, Lowy D, Poncelet S, Esser M, Matys K, Hildesheim A, Pinto LA, Herrero R, ... Safaeian M, et al. Comparison of antibody responses to human papillomavirus vaccination as measured by three assays. Frontiers in Oncology. 3: 328. PMID 24455487 DOI: 10.3389/Fonc.2013.00328 |
0.619 |
|
| 2014 |
Koshiol J, Sklavos M, Wentzensen N, Kemp T, Schiffman M, Dunn ST, Wang SS, Walker JL, Safaeian M, Zuna RE, Hildesheim A, Pfeiffer RM, Pinto LA. Evaluation of a multiplex panel of immune-related markers in cervical secretions: a methodologic study. International Journal of Cancer. Journal International Du Cancer. 134: 411-25. PMID 23824624 DOI: 10.1002/Ijc.28354 |
0.735 |
|
| 2013 |
Safaeian M, Porras C, Pan Y, Kreimer A, Schiller JT, Gonzalez P, Lowy DR, Wacholder S, Schiffman M, Rodriguez AC, Herrero R, Kemp T, Shelton G, Quint W, van Doorn LJ, et al. Durable antibody responses following one dose of the bivalent human papillomavirus L1 virus-like particle vaccine in the Costa Rica Vaccine Trial. Cancer Prevention Research (Philadelphia, Pa.). 6: 1242-50. PMID 24189371 DOI: 10.1158/1940-6207.Capr-13-0203 |
0.683 |
|
| 2013 |
Safaeian M, Sherman ME. From Papanicolaou to papillomaviruses: evolving challenges in cervical cancer screening in the era of human papillomavirus vaccination. Journal of the National Cancer Institute. 105: 1524-6. PMID 24096622 DOI: 10.1093/Jnci/Djt267 |
0.438 |
|
| 2013 |
Lang Kuhs KA, Gonzalez P, Struijk L, Castro F, Hildesheim A, van Doorn LJ, Rodriguez AC, Schiffman M, Quint W, Lowy DR, Porras C, Delvecchio C, Katki HA, Jimenez S, Safaeian M, et al. Prevalence of and risk factors for oral human papillomavirus among young women in Costa Rica. The Journal of Infectious Diseases. 208: 1643-52. PMID 24014882 DOI: 10.1093/Infdis/Jit369 |
0.701 |
|
| 2013 |
Safaeian M, Kemp TJ, Pan DY, Porras C, Rodriguez AC, Schiffman M, Cortes B, Katki H, Wacholder S, Schiller JT, Gonzalez P, Penrose K, Lowy DR, Quint W, van Doorn LJ, et al. Cross-protective vaccine efficacy of the bivalent HPV vaccine against HPV31 is associated with humoral immune responses: results from the Costa Rica Vaccine Trial. Human Vaccines & Immunotherapeutics. 9: 1399-406. PMID 23571174 DOI: 10.4161/Hv.24340 |
0.741 |
|
| 2013 |
Lin SW, Ghosh A, Porras C, Markt SC, Rodriguez AC, Schiffman M, Wacholder S, Kemp TJ, Pinto LA, Gonzalez P, Wentzensen N, Esser MT, Matys K, Meuree A, Quint W, ... ... Safaeian M, et al. HPV16 seropositivity and subsequent HPV16 infection risk in a naturally infected population: comparison of serological assays. Plos One. 8: e53067. PMID 23301022 DOI: 10.1371/Journal.Pone.0053067 |
0.735 |
|
| 2012 |
Kemp TJ, Safaeian M, Hildesheim A, Pan Y, Penrose KJ, Porras C, Schiller JT, Lowy DR, Herrero R, Pinto LA. Kinetic and HPV infection effects on cross-type neutralizing antibody and avidity responses induced by Cervarix(®). Vaccine. 31: 165-70. PMID 23123024 DOI: 10.1016/J.Vaccine.2012.10.067 |
0.643 |
|
| 2012 |
Safaeian M, Ghosh A, Porras C, Lin SW, Rodriguez AC, Schiffman M, Wacholder S, Kemp T, Gonzalez P, Wentzensen N, Esser M, Meuree A, Matys K, Quint W, van Doorn LJ, et al. Direct comparison of HPV16 serological assays used to define HPV-naïve women in HPV vaccine trials. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 21: 1547-54. PMID 22752082 DOI: 10.1158/1055-9965.Epi-12-0558 |
0.746 |
|
| 2012 |
Kemp TJ, Safaeian M, Miner S, Williams MC, Rodriguez AC, Herrero R, Hildesheim A, Pinto LA. Oral Immunoglobulin Levels are Not a Good Surrogate for Cervical Immunoglobulin Levels. Frontiers in Oncology. 2: 61. PMID 22737669 DOI: 10.3389/Fonc.2012.00061 |
0.445 |
|
| 2012 |
Safaeian M, Hildesheim A, Gonzalez P, Yu K, Porras C, Li Q, Rodriguez AC, Sherman ME, Schiffman M, Wacholder S, Burk R, Herrero R, Burdette L, Chanock SJ, Wang SS. Single nucleotide polymorphisms in the PRDX3 and RPS19 and risk of HPV persistence and cervical precancer/cancer. Plos One. 7: e33619. PMID 22496757 DOI: 10.1371/Journal.Pone.0033619 |
0.735 |
|
| 2012 |
Safaeian M, Wacholder S, Hildesheim A. Response: Re: Epidemiological study of anti-HPV16/18 seropositivity and subsequent risk of HPV16 and-18 infections Journal of the National Cancer Institute. 104: 163-164. DOI: 10.1093/jnci/djr519 |
0.62 |
|
| 2011 |
Coseo SE, Porras C, Dodd LE, Hildesheim A, Rodriguez AC, Schiffman M, Herrero R, Wacholder S, Gonzalez P, Sherman ME, Jimenez S, Solomon D, Bougelet C, van Doorn LJ, Quint W, ... Safaeian M, et al. Evaluation of the polyclonal ELISA HPV serology assay as a biomarker for human papillomavirus exposure. Sexually Transmitted Diseases. 38: 976-82. PMID 21934576 DOI: 10.1097/Olq.0B013E31822545C0 |
0.729 |
|
| 2011 |
Wentzensen N, Rodriguez AC, Viscidi R, Herrero R, Hildesheim A, Ghosh A, Morales J, Wacholder S, Guillen D, Alfaro M, Safaeian M, Burk RD, Schiffman M. A competitive serological assay shows naturally acquired immunity to human papillomavirus infections in the Guanacaste Natural History Study. The Journal of Infectious Diseases. 204: 94-102. PMID 21628663 DOI: 10.1093/Infdis/Jir209 |
0.694 |
|
| 2011 |
Kemp TJ, Hildesheim A, Safaeian M, Dauner JG, Pan Y, Porras C, Schiller JT, Lowy DR, Herrero R, Pinto LA. HPV16/18 L1 VLP vaccine induces cross-neutralizing antibodies that may mediate cross-protection. Vaccine. 29: 2011-4. PMID 21241731 DOI: 10.1016/J.Vaccine.2011.01.001 |
0.657 |
|
| 2010 |
Safaeian M, Quint K, Schiffman M, Rodriguez AC, Wacholder S, Herrero R, Hildesheim A, Viscidi RP, Quint W, Burk RD. Chlamydia trachomatis and risk of prevalent and incident cervical premalignancy in a population-based cohort. Journal of the National Cancer Institute. 102: 1794-804. PMID 21098758 DOI: 10.1093/Jnci/Djq436 |
0.729 |
|
| 2010 |
Safaeian M, Porras C, Schiffman M, Rodriguez AC, Wacholder S, Gonzalez P, Quint W, van Doorn LJ, Sherman ME, Xhenseval V, Herrero R, Hildesheim A. Epidemiological study of anti-HPV16/18 seropositivity and subsequent risk of HPV16 and -18 infections. Journal of the National Cancer Institute. 102: 1653-62. PMID 20944077 DOI: 10.1093/jnci/djq384 |
0.732 |
|
| 2010 |
Porras C, Bennett C, Safaeian M, Coseo S, Rodríguez AC, González P, Hutchinson M, Jiménez S, Sherman ME, Wacholder S, Solomon D, van Doorn LJ, Bougelet C, Quint W, Schiffman M, et al. Determinants of seropositivity among HPV-16/18 DNA positive young women. Bmc Infectious Diseases. 10: 238. PMID 20698998 DOI: 10.1186/1471-2334-10-238 |
0.746 |
|
| 2010 |
Coseo S, Porras C, Hildesheim A, Rodriguez AC, Schiffman M, Herrero R, Wacholder S, Gonzalez P, Wang SS, Sherman ME, Jimenez S, Solomon D, Bougelet C, van Doorn LJ, Quint W, ... Safaeian M, et al. Seroprevalence and correlates of human papillomavirus 16/18 seropositivity among young women in Costa Rica. Sexually Transmitted Diseases. 37: 706-14. PMID 20661178 DOI: 10.1097/Olq.0B013E3181E1A2C5 |
0.742 |
|
| 2010 |
Schiffman M, Rodriguez AC, Chen Z, Wacholder S, Herrero R, Hildesheim A, Desalle R, Befano B, Yu K, Safaeian M, Sherman ME, Morales J, Guillen D, Alfaro M, Hutchinson M, et al. A population-based prospective study of carcinogenic human papillomavirus variant lineages, viral persistence, and cervical neoplasia. Cancer Research. 70: 3159-69. PMID 20354192 DOI: 10.1158/0008-5472.Can-09-4179 |
0.747 |
|
| 2010 |
Wang SS, Gonzalez P, Yu K, Porras C, Li Q, Safaeian M, Rodriguez AC, Sherman ME, Bratti C, Schiffman M, Wacholder S, Burk RD, Herrero R, Chanock SJ, Hildesheim A. Common genetic variants and risk for HPV persistence and progression to cervical cancer. Plos One. 5: e8667. PMID 20084279 DOI: 10.1371/Journal.Pone.0008667 |
0.667 |
|
| 2010 |
Safaeian M, van Doorslaer K, Schiffman M, Chen Z, Rodriguez AC, Herrero R, Hildesheim A, Burk RD. Lack of heterogeneity of HPV16 E7 sequence compared with HPV31 and HPV73 may be related to its unique carcinogenic properties. Archives of Virology. 155: 367-70. PMID 20049619 DOI: 10.1007/S00705-009-0579-2 |
0.739 |
|
| 2010 |
Maucort-Boulch D, Plummer M, Castle PE, Demuth F, Safaeian M, Wheeler CM, Schiffman M. Predictors of human papillomavirus persistence among women with equivocal or mildly abnormal cytology. International Journal of Cancer. Journal International Du Cancer. 126: 684-91. PMID 19609952 DOI: 10.1002/Ijc.24752 |
0.716 |
|
| 2009 |
Safaeian M, Kemp T, Falk RT, Rodriguez AC, Hildesheim A, Williams M, Porras C, Herrero R, Pinto LA. Determinants and correlation of systemic and cervical concentrations of total IgA and IgG. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 18: 2672-6. PMID 19815637 DOI: 10.1158/1055-9965.Epi-09-0348 |
0.425 |
|
| 2009 |
Schiffman M, Safaeian M, Wentzensen N. The use of human papillomavirus seroepidemiology to inform vaccine policy. Sexually Transmitted Diseases. 36: 675-9. PMID 19773679 DOI: 10.1097/Olq.0B013E3181Bce102 |
0.728 |
|
| 2009 |
Safaeian M, Schiffman M, Gage J, Solomon D, Wheeler CM, Castle PE. Detection of precancerous cervical lesions is differential by human papillomavirus type. Cancer Research. 69: 3262-6. PMID 19351830 DOI: 10.1158/0008-5472.Can-08-4192 |
0.741 |
|
| 2009 |
Safaeian M, Falk RT, Rodriguez AC, Hildesheim A, Kemp T, Williams M, Morera L, Barrantes M, Herrero R, Porras C, Pinto L. Factors associated with fluctuations in IgA and IgG levels at the cervix during the menstrual cycle. The Journal of Infectious Diseases. 199: 455-63. PMID 19133811 DOI: 10.1086/596060 |
0.328 |
|
| 2009 |
Wang SS, Zuna RE, Wentzensen N, Dunn ST, Sherman ME, Gold MA, Schiffman M, Wacholder S, Allen RA, Block I, Downing K, Jeronimo J, Carreon JD, Safaeian M, Brown D, et al. Human papillomavirus cofactors by disease progression and human papillomavirus types in the study to understand cervical cancer early endpoints and determinants. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 18: 113-20. PMID 19124488 DOI: 10.1158/1055-9965.Epi-08-0591 |
0.755 |
|
| 2008 |
Safaeian M, Kiddugavu M, Gravitt PE, Gange SJ, Ssekasanvu J, Murokora D, Sklar M, Serwadda D, Wawer MJ, Shah KV, Gray R. Determinants of incidence and clearance of high-risk human papillomavirus infections in rural Rakai, Uganda. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 17: 1300-7. PMID 18559545 DOI: 10.1158/1055-9965.Epi-07-2678 |
0.715 |
|
| 2008 |
Porras C, Safaeian M, González P, Hildesheim A, Silva S, Schiffman M, Rodríguez AC, Wacholder S, Freer E, Quint K, Bratti C, Espinoza A, Cortes B, Herrero R. Epidemiology of genital chlamydia trachomatis infection among young women in Costa Rica Sexually Transmitted Diseases. 35: 461-468. PMID 18446086 DOI: 10.1097/Olq.0B013E3181644B4C |
0.418 |
|
| 2008 |
Safaeian M, Kiddugavu M, Gravitt PE, Gange SJ, Ssekasanvu J, Murokora D, Sklar M, Serwadda D, Wawer MJ, Shah KV, Gray R. Prevalence and risk factors for carcinogenic human papillomavirus infections in rural Rakai, Uganda. Sexually Transmitted Infections. 84: 306-11. PMID 18385223 DOI: 10.1136/Sti.2007.027318 |
0.708 |
|
| 2008 |
Gage JC, Safaeian M, Jeronimo J, Schiffman M. Spectroscopic imaging as triage test for cervical disease. Journal of Lower Genital Tract Disease. 12: 52-3. PMID 18162814 DOI: 10.1097/Lgt.0B013E318149E232 |
0.521 |
|
| 2007 |
Safaeian M, Solomon D, Castle PE. Cervical cancer prevention--cervical screening: science in evolution. Obstetrics and Gynecology Clinics of North America. 34: 739-60, ix. PMID 18061867 DOI: 10.1016/J.Ogc.2007.09.004 |
0.425 |
|
| 2007 |
Quint K, Porras C, Safaeian M, González P, Hildesheim A, Quint W, van Doorn LJ, Silva S, Melchers W, Schiffman M, Rodríguez AC, Wacholder S, Freer E, Cortes B, Herrero R, et al. Evaluation of a novel PCR-based assay for detection and identification of Chlamydia trachomatis serovars in cervical specimens. Journal of Clinical Microbiology. 45: 3986-91. PMID 17959760 DOI: 10.1128/JCM.01155-07 |
0.39 |
|
| 2007 |
Safaeian M, Solomon D, Wacholder S, Schiffman M, Castle P. Risk of precancer and follow-up management strategies for women with human papillomavirus-negative atypical squamous cells of undetermined significance. Obstetrics and Gynecology. 109: 1325-31. PMID 17540804 DOI: 10.1097/01.Aog.0000263461.71732.40 |
0.725 |
|
| 2007 |
Safaeian M, Herrero R, Hildesheim A, Quint W, Freer E, Van Doorn LJ, Porras C, Silva S, González P, Bratti MC, Rodriguez AC, Castle P. Comparison of the SPF10-LiPA system to the Hybrid Capture 2 Assay for detection of carcinogenic human papillomavirus genotypes among 5,683 young women in Guanacaste, Costa Rica. Journal of Clinical Microbiology. 45: 1447-54. PMID 17344361 DOI: 10.1128/Jcm.02580-06 |
0.677 |
|
| 2007 |
Safaeian M, Kiddugavu M, Gravitt PE, Ssekasanvu J, Murokora D, Sklar M, Serwadda D, Wawer MJ, Shah KV, Gray R. Comparability of self-collected vaginal swabs and physician-collected cervical swabs for detection of human papillomavirus infections in Rakai, Uganda. Sexually Transmitted Diseases. 34: 429-36. PMID 17075437 DOI: 10.1097/01.Olq.0000243623.67673.22 |
0.723 |
|
| 2001 |
Ahdieh L, Klein RS, Burk R, Cu-Uvin S, Schuman P, Duerr A, Safaeian M, Astemborski J, Daniel R, Shah K. Prevalence, incidence, and type-specific persistence of human papillomavirus in human immunodeficiency virus (HIV)-positive and HIV-negative women. The Journal of Infectious Diseases. 184: 682-90. PMID 11517428 DOI: 10.1086/323081 |
0.566 |
|
| Show low-probability matches. |